Category - Executive Moves

Executive Moves

Qualigen Therapeutics names Shishir Sinha to lead diagnostics division

Shishir Sinha Qualigen Therapeutics (NASDAQ:QLGN) appointed Shishir Sinha, the company’s newly promoted SVP and current COO, to lead its diagnostics division, FastPack. “With the return of the sales and...

April 29, 2022

Executive Moves

Sigyn Therapeutics names hepatology leader Dr. Donald Hillebrand to SAB

Dr. Donald Hillebrand Sigyn Therapeutics (OTC:SIGY) appointed Dr. Donald Hillebrand, M.D., to its scientific advisory board. Dr. Hillebrand is the associate medical director of liver transplantation at Saint...

April 26, 2022

Executive Moves

MindMed names Dr. Francois Lilienthal as CCO

Francois Lilienthal Mind Medicine (NASDAQ, NEO:MNMD) appointed Francois Lilienthal, M.D., as chief commercial officer to support the advancement of the company’s clinical development programs. Dr. Lilienthal has...

April 5, 2022

Executive Moves

RNA Disease Diagnostics adds chief scientific advisor, president to board

Dipanjan Pan RNA Disease Diagnostics (RNADD) appointed its chief scientific advisor, Prof. Dipanjan Pan, Ph.D., and company president, John Erickson, Jr., to the board to further position RNADD to execute the next...

April 4, 2022

Executive Moves

Sigyn Therapeutics names neurology leader Dr. Ajay Verma to SAB

Ajay Verma Sigyn Therapeutics (OTC:SIGY) appointed Ajay Verma, M.D., Ph.D., a recognized thought leader in the field of neurology, to its scientific advisory board. Dr. Verma’s extensive clinical experience and insights...

March 31, 2022

Executive Moves

Eric Cheng rejoins Maxim as head of healthcare investment banking

After an absence of five years, Eric Cheng has rejoined Maxim Group as a senior managing director and head of healthcare investment banking. Mr. Cheng held similar titles at Maxim between 2011 and 2017. Mr. Cheng brings...

March 29, 2022

Executive Moves

Long-time research analyst Anthony Petrone joins Mizuho Americas

Anthony Petrone Mizuho Americas hired Anthony Petrone as a managing director, senior medical devices, diagnostics and therapeutics equity research analyst. Mr. Petrone has more than 16 years of experience in...

March 28, 2022

Executive Moves

Long-time healthcare investment banker Jim Alfaro joins JMP

Jim Alfaro has joined JMP Securities as a managing director, healthcare investment banker, after a nearly 15-year stint with Maxim Group.

March 22, 2022

Executive Moves

Long-time healthcare investment banker Kee Colen joins Cantor Fitzgerald

Kee Colen has joined Cantor Fitzgerald as a managing director, healthcare investment banking, from Raymond James.

March 21, 2022

Executive Moves

Sigyn Therapeutics names leading nephrologist Dr. H. David Humes to SAB

Sigyn Therapeutics (OTC:SIGY) appointed internationally recognized nephrologist, H. David Humes, M.D., to its scientific advisory board. Dr. Humes recently played an instrumental role in the oversight of preclinical...

March 15, 2022

Category - Executive Moves

Qualigen Therapeutics names Shishir Sinha to lead diagnostics division

Sigyn Therapeutics names hepatology leader Dr. Donald Hillebrand to SAB

MindMed names Dr. Francois Lilienthal as CCO

RNA Disease Diagnostics adds chief scientific advisor, president to board

Sigyn Therapeutics names neurology leader Dr. Ajay Verma to SAB

Eric Cheng rejoins Maxim as head of healthcare investment banking

Long-time research analyst Anthony Petrone joins Mizuho Americas

Long-time healthcare investment banker Jim Alfaro joins JMP

Long-time healthcare investment banker Kee Colen joins Cantor Fitzgerald

Sigyn Therapeutics names leading nephrologist Dr. H. David Humes to SAB

General

More